As Big Pharma Loses Interest In New Antibiotics, Infections Are Only Growing Stronger
Existing drugs still treat most infections. But that has discouraged investment in new drugs that will be needed when — not if —the old ones fail.
Stay updated with breaking news from Sameer Kadri. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Existing drugs still treat most infections. But that has discouraged investment in new drugs that will be needed when — not if —the old ones fail.
Existing drugs still treat most infections. But that has discouraged investment in new drugs that will be needed when — not if —the old ones fail.
(Bloomberg) -- The number of new people getting the Covid-19 vaccine is at one of the lowest points since the rollout began, according to a review of the latest U.S. government data, even as average daily infections approach 800,000.
(Bloomberg) -- The Biden administration has assembled a group that will prepare new countermeasures for the emergence of future Covid-19 variants and other threats. Meantime, he faced calls from Democrats to improve his administration’s pandemic response, including access to at-home tests.
U.S. COVID hospitalizations hit new record high, raising risks for patients